Location History:
- Tampa, FL (US) (2016)
- Omaha, NE (US) (2016 - 2021)
Company Filing History:
6 out of 290 
3 out of 3 
2 out of 924 
Years Active: 2016-2021
Title: The Innovative Contributions of Rongshi Li
Introduction
Rongshi Li is a prominent inventor based in Omaha, NE, known for his significant contributions to the field of pharmaceuticals. With a total of eight patents to his name, he has made remarkable strides in developing innovative solutions for treating infectious diseases and cancers.
Latest Patents
Among his latest patents are the pyrrolomycin derivatives, which are designed to modulate Mcl-1 and inhibit the proliferation of bacteria and pathogens. These derivatives hold promise for treating various infectious diseases and cancers, showcasing the potential impact of his work on public health.
Career Highlights
Rongshi Li has worked with esteemed organizations such as the H. Lee Moffitt Cancer Center and Research Institute, Inc. and Chongqing Zein Pharmaceutical Co., Ltd. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Yan Liu and Said M Sebti, who have played a role in advancing his research initiatives. Their collaborative efforts have further enhanced the impact of his inventions.
Conclusion
Rongshi Li's innovative work in developing pyrrolomycin derivatives exemplifies his commitment to addressing critical health challenges. His contributions continue to pave the way for advancements in medical treatments and therapies.